Skip navigation
Home
Browse
Communities
& Collections
Browse Items by:
Issue Date
Author
Title
Advisor
Help
Sign on to:
My DSpace
Receive email
updates
Edit Profile
Adelaide Research & Scholarship
Adelaide Research & Scholarship
Search
Search:
All collections
Schools and Disciplines
School of Medicine
Medicine
Medicine publications
for
Current filters:
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Subject
Date Issued
Advisor
School
Department
Organisation
Equals
Contains
ID
Not Equals
Not Contains
Not ID
Results 1-10 of 42 (Search time: 0.002 seconds).
previous
1
2
3
4
...
5
next
Item hits:
Preview
Issue Date
Title
Author(s)
2015
KIR2DL5B genotype predicts outcomes in CML patients treated with response-directed sequential imatinib/nilotinib strategy
Yeung, D.
;
Tang, C.
;
Vidovic, L.
;
White, D.
;
Branford, S.
;
Hughes, T.
;
Yong, A.
2017
CYP2C8 genotype significantly alters imatinib metabolism in chronic myeloid leukaemia patients
Barratt, D.
;
Cox, H.
;
Menelaou, A.
;
Yeung, D.
;
White, D.
;
Hughes, T.
;
Somogyi, A.
2016
ABCB1 overexpression predicts outcome of CML patients undergoing first-line imatinib treatment
Eadie, L.
;
Hughes, T.
;
White, D.
;
New Directions in Leukaemia Research 2016 Meeting (NDLR) (16 Mar 2016 - 19 Mar 2016 : Noosa, QLD)
2017
CML patients with deep molecular responses to TKI have restored immune effectors and decreased PD-1 and immune suppressors
Hughes, A.
;
Clarson, J.
;
Tang, C.
;
Vidovic, L.
;
White, D.
;
Hughes, T.
;
Yong, A.
2016
BCR-ABL1 expression, RT-qPCR and treatment decisions in chronic myeloid leukaemia
Latham, S.
;
Bartley, P.
;
Budgen, B.
;
Ross, D.
;
Hughes, E.
;
Branford, S.
;
White, D.
;
Hughes, T.
;
Morley, A.
2012
Contrasting effects of diclofenac and ibuprofen on active imatinib uptake into leukaemic cells
Wang, J.
;
Hughes, T.
;
Kok, C.
;
Saunders, V.
;
Frede, A.
;
Groot Obbink, K.
;
Osborn, M.
;
Somogyi, A.
;
D'Andrea, R.
;
White, D.
2013
Which TKI? An embarrassment of riches for chronic myeloid leukemia patients
Hughes, T.
;
White, D.
2010
Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with Imatinib
White, D.
;
Dang, P.
;
Engler, J.
;
Frede, A.
;
Osborn, M.
;
Saunders, V.
;
Manley, P.
;
Zrim, S.
;
Hughes, T.
2013
Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy
Angelini, S.
;
Soverini, S.
;
Ravegnini, G.
;
Barnett, M.
;
Turrini, E.
;
Thornquist, M.
;
Pane, F.
;
Hughes, T.
;
White, D.
;
Radich, J.
;
Kim, D.
;
Saglio, G.
;
Cilloni, D.
;
Iacobucci, I.
;
Perini, G.
;
Woodman, R.
;
Cantelli-Forti, G.
;
Baccarani, M.
;
Hrelia, P.
;
Martinelli, G.
2015
Sustained inhibition of STAT5, but not JAK2, is essential for TKI-induced cell death in chronic myeloid leukemia
Schafranek, L.
;
Nievergall, E.
;
Powell, J.
;
Hiwase, D.
;
Leclercq, T.
;
Hughes, T.
;
White, D.
Discover
Author
13
Saunders, V.
9
Hiwase, D.
9
Kok, C.
9
Yeung, D.
7
Dang, P.
6
Branford, S.
6
Eadie, L.
6
Frede, A.
6
Ross, D.
5
Engler, J.
.
next >
Subject
23
Humans
18
Leukemia, Myelogenous, Chronic, B...
16
Pyrimidines
11
Imatinib Mesylate
11
Protein Kinase Inhibitors
10
Antineoplastic Agents
10
Piperazines
9
Benzamides
9
Female
9
Male
.
next >
Date issued
3
2018
7
2017
4
2016
2
2015
2
2014
10
2013
3
2012
4
2011
7
2010